破坏的整体HSC异质性是基本血小板血发展的基础
Jingyuan Tong1, Di Wang1, Haoze Song1
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 21, 2025
概括
基本血栓塞血症 (ET) 涉及影响造血干细胞 (HSCs) 的明显突变. 这项研究揭示了JAK2,CALR和MPL突变以及三负ET如何改变HSC功能并导致疾病,提供了新的治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 基本血小板血 (ET) 具有JAK2,CALR或MPL突变的特征,或是三阴性 (TN).
- 特定驱动突变对造血干细胞 (HSC) 异质性和ET病原性的影响尚未完全理解.
研究的目的:
- 用单细胞RNA测序研究不同ET亚型中HSC的分子特征.
- 阐明驱动突变和HSC子组改变在ET病原发生中的作用.
主要方法:
- 来自ET患者的HSC的单细胞RNA测序 (scRNA-seq).
- 在HSC中检测驱动突变 (JAK2,CALR,MPL).
- 对HSC子集的转录分析和比较分析.
主要成果:
- 发生MPL突变的HSC表现出异常代谢;发生CALR突变的HSC表现出活跃的细胞循环.
- 发生JAK2V617F突变的高细胞表现出增强的巨核细胞 (Mk) 起始和干扰素 (IFN) 反应.
- 在TN ET中,一种新的HSC子集类似于驱动器突变的HSC;减少的CXCR4+HSC倾斜骨髓分化并加速ET发病.
结论:
- 特定的驱动突变赋予ET中的HSC独特的分子特征.
- 改变的HSC异质性,特别是CXCR4+HSCs的丧失,有助于ET的病原性.
- 研究结果表明,有潜在的治疗策略可以针对ET中HSC功能障碍.
相关概念视频
01:24Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:19Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
01:30Venous Thrombosis I: Introduction
321
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
321
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
01:01Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K